 Acumen Pharmaceuticals, Inc. NASDAQ:ABOS Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants John Woolford - Investor Relations, Westwicke Daniel OConnell - President Chief Executive Officer Eric Siemers - Chief Medical Officer Matt Zuga - Chief Financial Officer Chief Business Officer Conference Call Participants Judah Frommer - Credit Suisse Tom Shrader - BTIG Ting Liu - UBS Operator Good day. Thank you for standing by, and welcome to the Acumen Pharmaceuticals, Second Quarter 2022 Update Call. 